A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer
Clinical trial NCT02721641 · COMPLETED
Trial details
- NCT number
- NCT02721641
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-06-01
- Primary completion
- 2015-02-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.